Unison Medicines is delighted to announce an oversubscribed first close of $500k of financing from a syndicate of highly sophisticated biopharma angels. Unison will use the proceeds to conduct a series of animal studies of [...]
More news
August 12th, 2024 - INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased [...]
Photos: NCCR AntiResist June 28th 2024 – INCATE, the INCubator for Antimicrobial Therapies in Europe, [...]
Just two days before the 8th AMR Conference opened its doors, the INCATE Selection Committee [...]
The AMR conference has established itself as the premier European conference on the topic of [...]
Basel was definitely the place to be in the week of 4th-8th March! Not only [...]
Basel is the place to be this week, and believe us when we say it [...]
February 2024 – Xiretsa, Inc is the second selected venture to receive INCATEs Stage II [...]
Do you have an outstanding antimicrobial resistance (AMR) innovation that you would like to share [...]
